Participating Countries Worldwide
Control of Cancer Development and Progression after Organ Transplantation
SiLVER Study
Initiated by Regensburg University Medical Center
endorsed by
A PROSPECTIVE RANDOMIZED,
OPEN-LABELED
TRIALCOMPARING
SIROLIMUS-CONTAINING
VERSUS
mTOR-INHIBITOR-FREE
IMMUNOSUPPRESSION
IN PATIENTS UNDERGOING
LIVER TRANSPLANTATION
FOR
HEPATOCELLULAR CARCINOMA